Interestingly, Segura-Diaz performed a targeted case-control study of 55 age-matched patients with PV and provided evidence for mutations in TET2 and higher risk of cardiovascular disease and thrombotic events [185]. The gene discussed is TET2; the disease is cardiovascular disorder.